Delivery Order SPE2DB25D3005-SPE2DB25FQFSU

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.94, is a firm fixed-price delivery order for the supply of IBSRELA 50 MG TABLET UU 60S, a medical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,224.15 firm fixed-price delivery order contract is for the supply of IBSRELA 50 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $80,719.27 firm fixed-price delivery order contract is for the supply of the prescription medication IBSRELA 50 MG TABLET. The contract has an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $13,341.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBSRELA 50 MG TABLET, a pharmaceutical product, with a completion date of May 8, 2025. The contract is a Firm Fixed Price Delivery Order, and it is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of IBSRELA 50 MG TABLET UU 60S. The contract, with a ceiling value of $6,486.85, is a delivery order type with firm fixed pricing. The period of performance is from the award date of October 11, 2024 through October 15, 2024. This contract award is not designated as a set-aside. AmerisourceBergen has a significant Indefinite...
This federal contract award is a Delivery Order valued at $10,091.76 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is with the Defense Logistics Agency (DLA), an agency within the Department of Defense, to provide the pharmaceutical product IBSRELA 50 MG TABLET UU 60S. The contract has an ultimate completion date of November 7, 2024 and utilizes a Firm Fixed Price pricing type. This award is not associated with a set-aside...
This federal contract award is for the delivery of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,928.73 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 21, 2025. The contract has an ultimate completion date of February 24, 2025 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,763.74 firm fixed-price delivery order is for the medical product "IBSRELA 50 MG TABLET UU 60S" with a completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,306.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of IBSRELA 50 MG TABLET, a pharmaceutical product, with a firm fixed price and an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $4,226.33, is for the delivery of IBSRELA 50 MG TABLET medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQFSU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,424.60. The contract is for the supply of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award indicates that no set-aside was used, suggesting open competition.

Generated 9/2/25, 9:43 AM